[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cdkn2c-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CDKN2C Gene",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05843253","Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant",[11],"Phase 2","RECRUITING","2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.388169Z"]